Key result
Recurrent functional mitral regurgitation grades ≥3 after repair increased reoperation with death as a competing risk compared to grades ≤2 (44.6% vs 14.6%; HR 3.69; 95% CI 1.17-11.6; P=0.026).
Why the study?
Functional mitral regurgitation is associated with increased mortality, but the value of mitral valve repair in this population remains unclear.
Does achieving a sustained reduction in functional mitral regurgitation (recurrent FMR grade ≤2) improve survival and freedom from reoperation compared to higher recurrent FMR grades (≥3) in patients undergoing surgical mitral valve repair?
Cohort (n=201)
Does achieving a sustained reduction in functional mitral regurgitation (recurrent FMR grade ≤2) improve survival and freedom from reoperation compared to higher recurrent FMR grades (≥3) in patients undergoing surgical mitral valve repair?
Achieving a durable reduction in functional mitral regurgitation (recurrent grade ≤2) after surgical mitral valve repair is associated with improved long-term survival and freedom from reoperation.
Functional mitral regurgitation (FMR) is associated with increased mortality and has been considered a marker for advanced heart disease, yet the value of mitral valve repair (MVr) in this population remains unclear. This study aims to evaluate the impact of reducing FMR burden through surgical MVr on survival. Patients with severe FMR who underwent MVr with an undersized, complete, rigid, annuloplasty between 2004 and 2017 were assessed (n = 201). Patients were categorized based on grade of recurrent FMR (0-4). Time-to-event Kaplan-Meier estimations of freedom from death or reoperation were performed using the log-rank test. Cox proportional hazards models evaluated all-cause mortality and reported in hazards ratios (HR) and 95% confidence intervals (CI). Patients were categorized by postoperative recurrent FMR: 45% (91/201) of patients had grade 0, 29% (58/201) grade 1, 20% (40/201) grade 2, 2% (4/201) grade 3%, and 4% (8/201) grade 4. The cumulative incidence of reoperation with death as a competing risk was higher in patients with grades ≥3 recurrent FMR compared to grades ≤2 (44.6% vs 14.6%, subhazard ratio 3.69 [95% CI, 1.17-11.6]; P = 0.026). Overall freedom from death or reoperation was superior for recurrent FMR grades ≤2 compared to grades ≥3 (log-rank P < 0.001). Increasing recurrent FMR grade was independently associated with mortality (HR 1.30 [95% CI, 1.07-1.59] P = 0.009). Reduced postoperative FMR grade resulted in an incrementally lower risk of death or reoperation after MVr. These results suggest that achieving a durable reduction in FMR burden improves long-term survival. Functional mitral regurgitation (FMR) is associated with increased mortality and has been considered a marker for advanced heart disease, yet the value of mitral valve repair (MVr) in this population remains unclear. This study aims to evaluate the impact of reducing FMR burden through surgical MVr on survival. Patients with severe FMR who underwent MVr with an undersized, complete, rigid, annuloplasty between 2004 and 2017 were assessed (n = 201). Patients were categorized based on grade of recurrent FMR (0-4). Time-to-event Kaplan-Meier estimations of freedom from death or reoperation were performed using the log-rank test. Cox proportional hazards models evaluated all-cause mortality and reported in hazards ratios (HR) and 95% confidence intervals (CI). Patients were categorized by postoperative recurrent FMR: 45% (91/201) of patients had grade 0, 29% (58/201) grade 1, 20% (40/201) grade 2, 2% (4/201) grade 3%, and 4% (8/201) grade 4. The cumulative incidence of reoperation with death as a competing risk was higher in patients with grades ≥3 recurrent FMR compared to grades ≤2 (44.6% vs 14.6%, subhazard ratio 3.69 [95% CI, 1.17-11.6]; P = 0.026). Overall freedom from death or reoperation was superior for recurrent FMR grades ≤2 compared to grades ≥3 (log-rank P < 0.001). Increasing recurrent FMR grade was independently associated with mortality (HR 1.30 [95% CI, 1.07-1.59] P = 0.009). Reduced postoperative FMR grade resulted in an incrementally lower risk of death or reoperation after MVr. These results suggest that achieving a durable reduction in FMR burden improves long-term survival. Central Picture Central Picture Central Picture LegendFreedom from death or reoperation by postoperative recurrent FMR grade. Central Picture Legend Freedom from death or reoperation by postoperative recurrent FMR grade. Central MessageReducing postoperative recurrent FMR results in a stepwise decrease in risk of death or reoperation after MVr. Importantly, achieving a sustained reduction in FMR burden improves long-term survival. Central Message Reducing postoperative recurrent FMR results in a stepwise decrease in risk of death or reoperation after MVr. Importantly, achieving a sustained reduction in FMR burden improves long-term survival. Perspective StatementFMR carries a mortality burden which improves with surgical reduction of FMR grade. Our findings indicate that reducing postoperative recurrent FMR grade results in a stepwise decrease in risk of death or reoperation after MVr. These results suggest that achieving a durable, sustained reduction in FMR burden improves long-term survival. Perspective Statement FMR carries a mortality burden which improves with surgical reduction of FMR grade. Our findings indicate that reducing postoperative recurrent FMR grade results in a stepwise decrease in risk of death or reoperation after MVr. These results suggest that achieving a durable, sustained reduction in FMR burden improves long-term survival.
No takes yet. Share an insight, caveat, or question.
Watt et al. (2023) conducted a cohort in Severe functional mitral regurgitation (n=201). Recurrent FMR grades ≥3 vs. Recurrent FMR grades ≤2 was evaluated on Reoperation with death as a competing risk (subhazard ratio 3.69, 95% CI 1.17-11.6, p=0.026). Recurrent functional mitral regurgitation grades ≥3 after repair increased reoperation with death as a competing risk compared to grades ≤2 (44.6% vs 14.6%; HR 3.69; 95% CI 1.17-11.6; P=0.026).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: